Quoin Pharmaceuticals Ltd DRC (QNRX NASDAQ) stock market data APIs
$4.1843
0.36(8.6%)
as of June 12, 2026
Try our APIs with
free plan!
Quoin Pharmaceuticals Ltd DRC Financial Data Overview
Price chart is built with
Anychart
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Prev. Close
4.1843
Open
4.5483
High
4.655
Low
4.1191
52 wk Range
4.1-23.5
Market Cap
8 435 K
Shares Outstanding
2 008 K
EPS
-1.77
Beta
1.748
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quoin Pharmaceuticals Ltd DRC data using free add-ons & libraries
Get Quoin Pharmaceuticals Ltd DRC Fundamental Data
Quoin Pharmaceuticals Ltd DRC Fundamental data includes:
- Net Revenue:
- EBITDA: -17 364 748
- Earnings Per Share: -10
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Quoin Pharmaceuticals Ltd DRC Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -2.26
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quoin Pharmaceuticals Ltd DRC News
New
Quoin Receives Japan's MHLW Orphan Drug For QRX003 In Treating Netherton Syndrome
(RTTNews) - Quoin Pharmaceuticals, Ltd. (QNRX), a late clinical-stage pharmaceutical company, announced that it has received the orphan drug designation for QRX003 from Japan's Ministry of Health, Lab...
Quoin Pharma Plans To Initiate QRX009 Trial For Pachyonychia Congenita In Q3 2026; Stock Up
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX), a late-stage clinical company, provided a clinical and regulatory update on its QRX009 topical rapamycin development programs. The firm noted that it pl...
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenit...
Quoin Updates On Type C Meet With FDA For QRX003 In NS; On Track To Initiate Phase 3 Trial In 2026
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX), a late-stage clinical company, provided a clinical and regulatory update following its recent Type C meeting with the U.S. Food and Drug Administration f...
Get Quoin Pharmaceuticals Ltd DRC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
